ALYXZO Trademark

Trademark Overview


On Monday, February 6, 2023, a trademark application was filed for ALYXZO with the United States Patent and Trademark Office. The USPTO has given the ALYXZO trademark a serial number of 97782409. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, July 17, 2024. This trademark is owned by Glaxo Group Limited. The ALYXZO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
alyxzo

General Information


Serial Number97782409
Word MarkALYXZO
Filing DateMonday, February 6, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, July 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Thursday, February 9, 2023NEW APPLICATION ENTERED
Friday, February 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 30, 2023ASSIGNED TO EXAMINER
Monday, November 6, 2023NON-FINAL ACTION WRITTEN
Monday, November 6, 2023NON-FINAL ACTION E-MAILED
Monday, November 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 3, 2024FINAL REFUSAL WRITTEN
Wednesday, January 3, 2024FINAL REFUSAL E-MAILED
Wednesday, January 3, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 17, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, July 17, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, March 21, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, March 21, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED